Fujimoto S, Miyazaki M, Endoh F, Takahashi O, Okui K, Sugibayashi K, Morimoto Y
Cancer Drug Deliv. 1985 Summer;2(3):173-81. doi: 10.1089/cdd.1985.2.173.
Biodegradable albumin microspheres containing about 5% mitomycin C (MMC) were prepared in an average diameter of 45 +/- 8 microns by heat denaturation in oil at 120 degrees C and/or cross-linking with glutaraldehyde. These MMC microspheres released, in vitro, about 20% of the contained MMC for over 3 days, and they were intra-arterially infused into albino rabbits and Wistar rats, as a preclinical model of intra-arterial infusion treatment for patients with inoperable hepatic tumor. We infused these microspheres into the femoral artery of rabbits with a VX-2 tumor implanted into the flank of the hindleg. High levels of MMC were maintained for several hours in the tumor and the entrapped MMC microspheres were detected within arterioles in the VX-2 tumors. The growth of VX-2 tumor was inhibited considerably, compared to findings in the control rabbits given conventional MMC. In the next studies, MMC microspheres were infused into the rat hepatic artery, and the levels of MMC in the hepatic vein blood were maintained at much the same concentration for over 2 hours after the infusion, in marked contrast to rapid decreases in the conventional MMC. Histologic findings revealed that MMC micro-spheres were entrapped within the hepatic arterioles for over 2 weeks and released biologically active MMC into the neighboring tissues for prolonged periods of time.
通过在120℃油中热变性和/或与戊二醛交联制备了含约5%丝裂霉素C(MMC)的可生物降解白蛋白微球,其平均直径为45±8微米。这些MMC微球在体外3天内释放了约20%所含的MMC,并作为不可切除性肝肿瘤患者动脉内灌注治疗的临床前模型,将其动脉内注入白化兔和Wistar大鼠体内。我们将这些微球注入后肢侧腹植入VX-2肿瘤的兔股动脉。肿瘤内MMC水平维持数小时,且在VX-2肿瘤的小动脉内检测到截留的MMC微球。与给予传统MMC的对照兔相比,VX-2肿瘤的生长受到显著抑制。在接下来的研究中,将MMC微球注入大鼠肝动脉,注入后肝静脉血中MMC水平在2小时以上维持在大致相同的浓度,这与传统MMC的迅速下降形成显著对比。组织学结果显示,MMC微球在肝小动脉内截留超过2周,并长时间向邻近组织释放生物活性MMC。